Novo Nordisk shares jump almost 8% after US approves Wegovy pill
The approval gives the drugmaker a first-mover advantage in the race for a potent oral weight-loss medicine Novo Nordisk shares ...
The approval gives the drugmaker a first-mover advantage in the race for a potent oral weight-loss medicine Novo Nordisk shares ...
The price for a month’s supply of the starter dose of Wegovy will be 1,400 yuanNovo Nordisk said on Monday ...
PATIENTS using Novo Nordisk’s wildly popular weigh-loss drug Wegovy and its similar medicines for type two diabetes may be at ...
Breadcrumb Trail LinksNewsCanadaThe study is the first to link the wildly popular weight-loss drugs with a higher risk of developing ...
The US Food and Drug Administration has given the green light for a popular anti-obesity drug to be used to ...
The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.
Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.
© 2026 The New York Journals. All Rights Reserved.